Skip to content

The quality of life of multiple sclerosis patients in Europe

The quality of life of multiple sclerosis patients in Europe

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN78466206
Enrollment
250
Registered
2019-08-13
Start date
2019-06-26
Completion date
Unknown
Last updated
2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple sclerosis Nervous System Diseases Multiple sclerosis

Interventions

The online questionnaire consists of questions about patient demographics, clinical characteristics, quality of life measures (using the multiple sclerosis quality of life (MSQOL)-54), health state (u

Sponsors

Erasmus School of Health Policy & Management
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with clinically definite multiple sclerosis (relapsing-remitting MS, secondary progressive MS, primary progressive MS) 2. Age 18 years or older 3. No restrictions whether patients are or are not using immunomodulatory therapy, or have used other therapies in the past 4. Participants have to have access to internet and the OPTOGENERAPY website to fill in the online questionnaire

Exclusion criteria

Exclusion criteria: Patients with a co-morbidity that negatively influences their cognition (for example dementia, stroke)

Design outcomes

Primary

MeasureTime frame
1. Quality of life measured using MSQOL-54 2. Health status measured using EQ-5D-5L Both outcomes measured at a single timepoint, when the participant fills out the questionnaire

Secondary

MeasureTime frame
Clinical and treatment characteristics, measured by questionnaire at a single timepoint, when the participant fills out the questionnaire

Countries

France, Germany, Italy, Netherlands, United Kingdom

Contacts

Public ContactLaurenske Visser
l.a.visser@eshpm.eur.nl+31 (0)10 408 8648

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026